全文获取类型
收费全文 | 233200篇 |
免费 | 52006篇 |
国内免费 | 1395篇 |
专业分类
耳鼻咽喉 | 3664篇 |
儿科学 | 7053篇 |
妇产科学 | 4304篇 |
基础医学 | 39223篇 |
口腔科学 | 8102篇 |
临床医学 | 27138篇 |
内科学 | 52136篇 |
皮肤病学 | 11599篇 |
神经病学 | 24821篇 |
特种医学 | 10495篇 |
外国民族医学 | 3篇 |
外科学 | 35144篇 |
综合类 | 2382篇 |
现状与发展 | 5篇 |
一般理论 | 102篇 |
预防医学 | 13693篇 |
眼科学 | 5695篇 |
药学 | 19216篇 |
3篇 | |
中国医学 | 2529篇 |
肿瘤学 | 19294篇 |
出版年
2023年 | 814篇 |
2022年 | 2207篇 |
2021年 | 6232篇 |
2020年 | 7288篇 |
2019年 | 13726篇 |
2018年 | 13968篇 |
2017年 | 13948篇 |
2016年 | 15512篇 |
2015年 | 16948篇 |
2014年 | 18266篇 |
2013年 | 20141篇 |
2012年 | 16984篇 |
2011年 | 16558篇 |
2010年 | 15802篇 |
2009年 | 11234篇 |
2008年 | 11450篇 |
2007年 | 10187篇 |
2006年 | 9434篇 |
2005年 | 8817篇 |
2004年 | 7858篇 |
2003年 | 6952篇 |
2002年 | 6193篇 |
2001年 | 5144篇 |
2000年 | 4711篇 |
1999年 | 3551篇 |
1998年 | 1370篇 |
1997年 | 1040篇 |
1996年 | 980篇 |
1995年 | 888篇 |
1994年 | 777篇 |
1993年 | 665篇 |
1992年 | 1601篇 |
1991年 | 1594篇 |
1990年 | 1369篇 |
1989年 | 1256篇 |
1988年 | 1162篇 |
1987年 | 1041篇 |
1986年 | 1024篇 |
1985年 | 889篇 |
1984年 | 656篇 |
1983年 | 569篇 |
1982年 | 404篇 |
1981年 | 389篇 |
1980年 | 342篇 |
1979年 | 527篇 |
1978年 | 411篇 |
1977年 | 393篇 |
1976年 | 348篇 |
1974年 | 363篇 |
1973年 | 329篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
111.
Leyi Wang Saraswathi Lanka Debbie Cassout Nohra E. Mateus‐Pinilla Ganwu Li William C. Wilson Dongwan Yoo Paul Shelton Richard L. Fredrickson 《Transboundary and Emerging Diseases》2019,66(5):1809-1820
First described in 1955 in New Jersey, epizootic haemorrhagic disease (EHD) causes a severe clinical disease in wild and domestic ruminants worldwide. Epizootic haemorrhagic disease outbreaks occur in deer populations each year from summer to late autumn. The etiological agent is EHD virus (EHDV) which is a double‐stranded segmented icosahedral RNA virus. EHD virus utilizes point mutations and reassortment strategies to maintain viral fitness during infection. In 2018, EHDV serotype 2 was predominantly detected in deer in Illinois. Whole genome sequencing was conducted for two 2018 EHDV2 isolates (IL41747 and IL42218) and the sequence analyses indicated that IL42218 was a reassortant between different serotypes whereas IL41747 was a genetically stable strain. Our data suggest that multiple strains contribute to outbreaks each year. 相似文献
112.
113.
114.
Mei-Yi Wu Yu-Wei Chen Lie-Yee Hung Chii-Hong Lee Hsin-An Chen Yung-Ho Hsu Mai-Szu Wu 《Transplantation proceedings》2019,51(5):1472-1474
IntroductionThe immunosuppressant agents in kidney transplantation (KT) may lead to various complications such as opportunistic infections and malignancies. BK virus associated nephropathy is a significant complication following KT, and it can result in graft failure. BK virus causes tubulointerstitial nephritis, ureter stenosis, and even graft failure in KT recipients with impaired immune system. We described a 63-year-old woman, who was a hepatitis C carrier and on dialysis for 22 years before KT, who received cadaveric-donor KT 2 years previously. She reported decreasing urine output and general weakness. The serum creatinine level was slightly increased from 2.94 to 4.38 mg/dL.MethodsImmunosuppressant medications including prednisolone, everolimus, cyclosporin, and mycophenolate sodium were continued as maintenance therapy post KT. Kidney biopsy was performed due to deterioration of graft function.ResultsThe kidney biopsy showed consistent results with early-stage polyomavirus nephropathy, characterized by focal viral cytopathic changes with positive immunohistochemical signals and mesangial proliferative glomerulonephritis, immune-complex-mediated (Fig 1 and Fig 2). Negative C4d staining at peritubular capillary was reported. The dosage of mycophenolate sodium was tapered from 720 to 360 mg daily and that of everolimus increased from 0.5 to 1.0 mg daily due to BK viral infection with BK nephropathy. The serum creatinine level was 2.75 mg/dL after treatment.ConclusionEarly detection of BK nephropathy and decreasing immunosuppressant agents are the mainstay of treatment. Substituting leflunomide for mycophenolate sodium and increasing dosage of everolimus has been proposed to solve BK nephropathy. We presented that the use of leflunomide in such situation is in a timely manner. 相似文献
115.
116.
No national epidemiological investigations have been conducted recently regarding facial lacerations. The study was performed using the data of 3,634,229 people during the 5-year period from 2014 to 2018 archived by the National Health Information Database (NHID) of the Health Insurance Review and Assessment Service. Preschool and children under 10 years old accounted for about one-third of patients. Facial lacerations were concentrated in the “T-shaped” area, which comprised forehead, nose, lips, and the perioral area. The male to female ratio for all study subjects was 2.16:1. Age and gender are significantly related with each other (P < .001). Mean hospital stays decreased, and numbers of outpatient department visits per patient were highest for hospitals and lowest for health agencies. Over the study period, hospital costs per patient in tertiary and general hospitals increased gradually. Preschool and school-aged children are vulnerable to trauma. Male patients outnumbered female patients by a factor of more than 2. The “T-shaped’” area around forehead is vulnerable to injury. Total cost of medical care benefits per patient in tertiary hospitals was about 7 times on average than in health agencies. Regarding functional, behavioral, and aesthetic outcomes, more attention should be paid to epidemiologic data and hospital costs for facial lacerations. 相似文献
117.
118.
119.
120.
Tuberculosis (TB) remains one of a major health problem worldwide. Tuberculosis vaccine research has made an extraordinary progress over the past few years. However, there is still no replacement for the Bacillus Calmette‐Guérin vaccine, the only TB vaccine licensed for human use. Therefore, the discovery and development of new TB vaccines remains a priority. This article discusses current strategies used to diversify TB vaccines and includes discussion of the status of efforts to improve protection against Mycobacterium tuberculosis (M tb) infection or TB disease by developing new and safe TB vaccines. This article also highlights the current research efforts in immune‐enhancing approaches to improve vaccination efficacy. The development of more effective TB vaccines might have significant impact on global TB control. 相似文献